Effect of Cholesterol Lowering Medicines on Blood Sugar and Pancreatic Enzyme Levels in Patients with High Cholesterol
Phase 4
Completed
- Conditions
- Health Condition 1: null- DYSLIPIDEMIA
- Registration Number
- CTRI/2014/07/004714
- Lead Sponsor
- SREE MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 71
Inclusion Criteria
1) Hyperlipedimic patients with lipid profile:
a)Total Cholesterol â?? 200 - 500 mg/dl.
b)Triglycerides â?? 150-600 mg/dl.
c)Low density lipoprotein â?? 100-400 mg/dl.
d)High density lipoprotein - <55 mg/dl.
e)Very low density lipoprotein â?? 10-33 mg/dl.
2) Both sex.
3) Age : 20-60 years.
Exclusion Criteria
1) Alcoholics.
2) Family H/O pancreatitis.
3) H/O Diabetes.
4) H/O Hypertension.
5) H/O Drug intake â??
i.Azathioprine.
ii.6-mercaptopurine.
iii.Sulfonamides.
iv.Estrogens.
v.Tetracycline.
vi.Vincristine.
vii.valproic acid.
viii.Steroids.
ix.Anti-HIV medications.
6) H/O Pancreatic cancer.
7) H/O Renal failure.
8) H/O Endoscopic Retrograde Cholangiopancreatography.
9) Pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method i.Serum lipase in Units per Liter [U/L]. <br/ ><br>ii.Blood glucose in milligram per deciliter [mg/dl]. <br/ ><br>Timepoint: THREE MONTHS
- Secondary Outcome Measures
Name Time Method a)Total Cholesterol <br/ ><br>b)Triglycerides <br/ ><br>c)Low density lipoprotein <br/ ><br>d)High density lipoprotein <br/ ><br>e)Very low density lipoprotein <br/ ><br>Timepoint: THREE MONTHS